MontLake Invenomic US Equity Long/Short UCITS Fund

Investment Objective

The objective of the Fund is to achieve long-term capital appreciation. To achieve this, the Invenomic strategy adopts 3 core principles: 1) investing in fundamentally sound companies 2) disciplined short selling and 3) diversification – an essential risk management tool. The strategy employs a value-biased, sector agnostic and long/short approach, investing in all-cap equities predominantly within North America. 

Latest Meeting Note

Meeting 28 Jun 2022

The MontLake Invenomic US Equity Long/Short UCITS fund launched on the MontLake platform in September 2021 with $35m of seed capital and has scaled rapidly. The fund is managed by Ali Motamed (ex Boston Partners), founder of Invenomic Ca... Read more

The MontLake Invenomic US Equity Long/Short UCITS fund launched on the MontLake platform in September 2021 with $35m of seed capital and has scaled rapidly. The fund is managed by Ali Motamed (ex Boston Partners), founder of Invenomic Capital Management. The strategy is fundamentally driven US equity long short with a market-cap agnostic approach. The fund is built around three core principles; investing in fundamentally sound companies, disciplined short selling, and diversification, which is used as an essential tool in risk management. On the long side, the approach is value biased with a focus on sustainable free cash flow generation. Ali looks for businesses that have enduring barriers to entry, long consistent histories, and companies that demonstrate a sensible and defined capital deployment strategy. On the short side the portfolio is stock-specific and is focused on companies that are expected to generate real negative returns, centred around three main types; stocks have negative free cash flow, businesses where with poor pricing powers, and companies where valuations are inflated due to unsustainable events.

Performance

JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC YTD
2021 0.1 0.4 0.7 0.4 0.3 0.3 0.8 0.5 0.7 0.2 0.5 0.1 0.3
2020 0.6 0.5 0.3 0.6 0.6 0.7 0.8 0.3 0.1 0.4 0.2 0.3 0.7

or Register for Free

  • Access the full universe of UCITS Hedge Funds and Absolute Return Funds.
  • Build and curate a watchlist.
  • View the latest research.
Close Current Site Absolute Hedge is a market leading UCITS research database providing proprietary research on funds, themes and strategies in the UCITS space. Kepler Trust Intelligence is produced by the investment companies team at Kepler Partners and is the UK’s premier source of detailed qualitative research on investment trusts. Kepler Liquid Strategies is a Dublin domiciled UCITS fund platform featuring a number of best-of-breed fund managers. Kepler Partners is a corporate advisory and asset raising boutique specialising in the regulated funds market in Europe and investment trusts in the UK.